San Diego, CA, November 15, 2018 /PRNewswire/ -- HealthLytix, a precision health company and developer of quantitative medical imaging solutions that leverage machine learning, today announced a new distribution agreement with CorTechs Labs, a leading medical software innovator that provides market leading solutions for quantitative brain volume analysis. The agreement enables CorTechs Labs to resell HealthLytix’s new head CT software called CT CoPilot™, alongside its NeuroQuant® product line, and expands upon an existing strategic partnership between the two companies.
“We are pleased to align with an established organization like CorTechs Labs, which can speed market access, increase our visibility, and enable radiologists to quickly realize the efficiency and clinical confidence benefits that CT CoPilot can enable,” says Ajit Shankaranarayanan, COO at HealthLytix. “Our focus on head CT imaging complements CorTechs Labs’ focus on quantitative brain MRI.”
CT CoPilot seamlessly integrates into existing clinical workflow to improve radiologist efficiency, measurement accuracy, and clinical confidence by automatically providing consistent views of head CT exams. It also generates automated quantitative measurements and subtraction series to increase conspicuity of change between exams.
“HealthLytix’s cutting-edge quantitative CT imaging solution dovetails perfectly with our mission to streamline radiological workflow through our industry-leading brain image analysis solutions,” says Chris Airriess, COO at CorTechs Labs. “We believe that our customers will instantly recognize the value that CT CoPilot will bring to their practice.”
CT CoPilot will be demonstrated at the upcoming Radiological Society of North America (RSNA) 2018 annual meeting in Chicago. HealthLytix personnel will be available to discuss the benefits and capabilities of CT CoPilot in the CorTechs Labs Booth (#7944 – North Hall) at RSNA.
About HealthLytix:
At HealthLytix, we create data analytics solutions to provide comprehensive insights into health status based on genetics, quantitative imaging, and other medical information. Our products provide consumers with the benefits of early detection and targeted care, while empowering physicians with more accurate clinical decision-making across medical imaging modalities. As a precision health company, we apply proprietary machine learning algorithms to create individualized wellness assessments. We enable physicians and health systems to understand patient data, personalize treatment solutions, and leverage data-driven insights into care pathway management. Learn more at www.healthlytix.com and in our virtual press kit.
About CorTechs Labs:
CorTechs Labs develops and markets breakthrough medical device software solutions capable of automatically segmenting and quantifying brain structures, making quantitative analysis of the human brain a routine part of clinical practice. CorTechs Labs’ cutting-edge brain imaging analysis provides neurologists, radiologists, and clinical researchers worldwide with a convenient and cost-effective means to quantify subcortical structures to help assess a variety of neurological conditions, such as Alzheimer's disease, epilepsy, multiple sclerosis, brain trauma, and brain development abnormalities. Please visit www.cortechslabs.com for further information.